|
A landmark compilation of start-up companies and scientific advances paving the way in emerging biotech markets.
The publishers of BioWorld Today have released Innovations in Biotechnology 2008: Development-Stage Companies and Scientific Findings Leading the Way. This executive report focuses on the innovative companies leading a new wave of development, and the scientific discoveries that will underpin the next wave of advances.
We pinpoint the firms and scientific advances shaping biotech's next generation, including companies making news and those quietly flying under the radar.
The Innovations in Biotechnology 2008 is priced at $599, plus $17.95 in shipping and handling.
You can review this product for 30 days. If you cancel within 30 days of receipt, you will receive a full credit upon return of the product together with a request for cancellation.
Click here to view an index of the companies covered in this report.
Innovations in Biotechnology 2008 sifts through the myriad scientific developments and key journal-published studies and highlights those that offer the most significance for the future of biotechnology:
- Cancer and tumors
- Immune system and infections
- Gene therapy
- Drug discovery and delivery
- Neuroscience
- Stem cells
People who need this report include:
- Biotechnology and pharmaceutical executives
- Analysts and investors
- Attorneys and patent officers
- Research and development directors
- Technology transfer officers
By combining more than 200 pages of analysis on these start-up companies and scientific trends,
Innovations in Biotechnology 2008: Development-Stage Companies and Scientific Findings Leading the Way provides the perfect resource for understanding the current state and future of the emerging companies and trends in the biotechnology market
Innovations in Biotechnology 2008 can be purchased in print or PDF.
|
Print and PDF Version:
|
|
Report-Only Price: $599 + $17.95 s&h
|
Order Now
|
|
